Proteomic Investigation of the Antibacterial Mechanism of Cefiderocol against Escherichia coli

Authors:

Abstract
CFDC was the first FDA-approved siderophore cephalosporin antibiotic in 2019 and is known for its Trojan horse tactics and broad antimicrobial activity against Gram-negative bacteria. However, its antibacterial mechanism is not fully understood, and whether it has an impact on in vivo iron ion homeostasis remains unknown.
Funding Information
  • Excellent Young Talents Fund Program of Zunyi Medical University (18zy-005)
  • Outstanding Talents Research Start-up Foundation of Xuzhou Medical University (RC20552039)
  • National Natural Science Foundation of China (81860356)
  • Natural Science Foundation of Guizhou Province (QKH-J [2020]1Y352)

This publication has 55 references indexed in Scilit: